Abstract
The purpose of this study was to assess adherence to sulfonylurea monotherapy within a Native American population with type 2 diabetes mellitus. Patient medication adherence was evaluated using medical records to perform a 12-month, cross-sectional evaluation of medication refills. Adherence was defined using a continuous, multiple-interval measure of medication availability (CMA). Patients had an average of 80.5 ± 25.4 days of medication during 100 days of treatment, equivalent to a defined adherence scale of fair to poor in 58%. Because CMA may be less expensive and time- consuming than other measures of medication adherence, CMA can be used to assess medication adherence in patients at risk for developing diabetes complications, such as Native Americans.
| Original language | English |
|---|---|
| Pages (from-to) | 41-49 |
| Number of pages | 9 |
| Journal | Journal of Pharmacoepidemiology |
| Volume | 8 |
| Issue number | 1 |
| DOIs | |
| State | Published - 2000 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Pharmacology (medical)
- Pharmacology, Toxicology and Pharmaceutics(all)
Cite this
Sulfonylurea adherence and glycemic control in native Americans with type 2 diabetes mellitus. / Kruse, Michael W.; Monaghan, Michael S.; Troshynski, Thomas J.
In: Journal of Pharmacoepidemiology, Vol. 8, No. 1, 2000, p. 41-49.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Sulfonylurea adherence and glycemic control in native Americans with type 2 diabetes mellitus
AU - Kruse, Michael W.
AU - Monaghan, Michael S.
AU - Troshynski, Thomas J.
PY - 2000
Y1 - 2000
N2 - The purpose of this study was to assess adherence to sulfonylurea monotherapy within a Native American population with type 2 diabetes mellitus. Patient medication adherence was evaluated using medical records to perform a 12-month, cross-sectional evaluation of medication refills. Adherence was defined using a continuous, multiple-interval measure of medication availability (CMA). Patients had an average of 80.5 ± 25.4 days of medication during 100 days of treatment, equivalent to a defined adherence scale of fair to poor in 58%. Because CMA may be less expensive and time- consuming than other measures of medication adherence, CMA can be used to assess medication adherence in patients at risk for developing diabetes complications, such as Native Americans.
AB - The purpose of this study was to assess adherence to sulfonylurea monotherapy within a Native American population with type 2 diabetes mellitus. Patient medication adherence was evaluated using medical records to perform a 12-month, cross-sectional evaluation of medication refills. Adherence was defined using a continuous, multiple-interval measure of medication availability (CMA). Patients had an average of 80.5 ± 25.4 days of medication during 100 days of treatment, equivalent to a defined adherence scale of fair to poor in 58%. Because CMA may be less expensive and time- consuming than other measures of medication adherence, CMA can be used to assess medication adherence in patients at risk for developing diabetes complications, such as Native Americans.
UR - http://www.scopus.com/inward/record.url?scp=0033992135&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033992135&partnerID=8YFLogxK
U2 - 10.1300/J055v08n01_03
DO - 10.1300/J055v08n01_03
M3 - Article
AN - SCOPUS:0033992135
VL - 8
SP - 41
EP - 49
JO - Journal of Pharmacoepidemiology
JF - Journal of Pharmacoepidemiology
SN - 0896-6966
IS - 1
ER -